We are increasingly teaching children to interpret the world through the binary of oppressor and oppressed, enforcing a ...

Apple has unveiled watchOS 27 with Siri AI, smarter fitness tools, Apple Intelligence integration, redesigned apps, and improved everyday assistance for Apple Watch users. The Latest Tech News, Delive ...

Apple’s watchOS 27 brings Siri AI, smarter widgets, improved workout tools, and several smaller quality-of-life upgrades. Here’s everything new coming to the Apple Watch.The Latest Tech News, Delivere ...

Today dentsu and CreatorIQ, the global operating system for creator-led growth, announced a first-of-its-kind data partnership integrating dentsu's proprietary audience strategy and insights platform, ...

The premium TV segment in India has never looked more exciting. With OLED technology pushing picture quality to new heights and AI-powered smart features making the experience more personal than ever, ...

“People just really want to take back control of their time, their lives, their attention... They’re down for whatever helps them do that.” ...

Andy is a seasoned technology journalist with more than 15 years experience in the mobile industry, writing for Digital Trends, Wired, and more. Andy has reviewed hundreds of smartphones and tablets, ...

While watchOS 27 didn’t get much stage time during WWDC 2026, the next Apple Watch software update still packs some great new features. Here’s everything new coming to Apple Watch this fall so far.

The biggest winners today are breaking a core rule of modern strategy. Here’s why owning more—not less—is suddenly the smartest move in business.

YouTube Premium has been a topic of fierce debate over the years, with some users baffled that anybody would pay to avoid ads on the video platform while others insist it's worth every penny. That ...

Thank you, operator. Good morning, and welcome to the Acuity Fiscal 2026 Third Quarter Earnings Call. On the call with me this morning are Neil Ashe, our Chairman, President and Chief Executive ...

BMS presented trial results from mezigdomide and arlocabtagene autoleucel at EHA 2026. Credit: Tada Images/Shutterstock.com. Bristol Myers Squibb (BMS) has revealed clinical data for two pipeline ...